
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
Author(s) -
Daniel L. Hertz,
S. Roy,
Alison A. MotsingerReif,
A. Drobish,
L. S. Clark,
Howard L. McLeod,
L. A. Carey,
E. C. Dees
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/q1m1-ke46
Subject(s) - paclitaxel , medicine , breast cancer , oncology , cancer